News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

William Barlow

Articles by William Barlow

31 TIP TROPION-Breast03: Datopotamab Deruxtecan (Dato-DXd) ± Durvalumab vs Investigator’s Choice of Therapy (ICT) for Triple-Negative Breast Cancer (TNBC) with Residual Disease Following Neoadjuvant Therapy

ByAditya Bardia, MD, MPH, FASCO,Lajos Pusztai, MD, DPhil,Kathy S. Albain, MD,Kevin Kalinsky, MD, MS,Dawn Herman,William Barlow,Claudine Isaacs, MD,Micah Maxwell,Nadia Harbeck, MD, PhD,Priyanka Sharma, MD

April 27th 2023

Latest Updated Articles

Trending on CancerNetwork

Radiotherapy Dose Escalation Did Not Improve Efficacy/QOL in Anal Cancer

FDA Grants Breakthrough Therapy Designation to ICT01 in Frontline AML

Nogapendekin Alfa Combo Earns Approval in Saudi Arabia for Metastatic NSCLC

Gemogenovatucel-T Exhibits Survival Benefit in Epithelial Ovarian Cancer

Taiwan FDA Approves Nivolumab/Ipilimumab for MSI-H/dMMR Metastatic CRC